✦ LIBER ✦

Autoimmune Hemolytic Anemia as a Risk Factor of Poor Outcome in Patients with Splenic Marginal Zone Lymphoma

✍ Scribed by Aniko Fodor; Miklos Zsolt Molnar; Laszlo Krenacs; Eniko Bagdi; Judit Csomor; Andras Matolcsy; Judit Demeter

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of rituximab in autoimmune hemo

✍ Claudio Fozza; Antonio Galleu; Maria Grazia Careddu; Domenica Barbara Giannico; 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 49 KB

Activity of Rituximab Monotherapy in Ref

✍ Fabbri, Alberto; Gozzetti, Alessandro; Lazzi, Stefano; Lenoci, Mariapia; D'Amuri 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 1014 KB

45 High frequency and prognostic importa

✍ A. Fodor; I. Hoffer; L. Krenács; E. Bagdi; J. Csomor; A. Matolcsy; M.Z. Molnár; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Splenic marginal zone lymphoma with or w

✍ Emilio Iannitto; Achille Ambrosetti; Emanuele Ammatuna; Maura Colosio; Ada M. Fl 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB